Coronavirus Disease-2019 Survival in Mexico: A Cohort Study on the Interaction of the Associated Factors

被引:4
|
作者
Marquez-Gonzalez, Horacio [1 ]
Mendez-Galvan, Jorge F. [2 ]
Reyes-Lopez, Alfonso [3 ]
Klunder-Klunder, Miguel [4 ]
Jimenez-Juarez, Rodolfo [5 ]
Garduno-Espinosa, Juan [6 ]
Solorzano-Santos, Fortino [7 ]
机构
[1] Hosp Infantii Mexico Federico Gomez, Dept Clin Res, Mexico City, DF, Mexico
[2] Hosp Infantil Mexico Dr Federico Gomez, Ctr Res Emerging Dis, Mexico City, DF, Mexico
[3] Hosp Infantil Mexico Dr Federico Gomez, Ctr Hlth Econ, Mexico City, DF, Mexico
[4] Hosp Infantil Mexico Dr Federico Gomez, Res Management, Mexico City, DF, Mexico
[5] Hosp Infantil Mexico Dr Federico Gomez, Clin Infect Dis Dept, Mexico City, DF, Mexico
[6] Hosp Infantil Mexico Dr Federico Gomez, Clin Res Direct, Mexico City, DF, Mexico
[7] Hosp Infantil Mexico Federico GomezMexico Federic, Infect Dis Res Dept, Mexico City, DF, Mexico
关键词
Mexico; SARS-CoV-2; survival analysis; cohort study; comorbidity; COVID-19; outbreak; CLINICAL CHARACTERISTICS; SARS-COV-2; INFECTION; COVID-19; COMORBIDITIES;
D O I
10.3389/fpubh.2021.660114
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The pandemic caused by the new coronavirus Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is currently affecting more than 200 countries. The most lethal clinical presentation is respiratory insufficiency, requiring attention in intensive care units (ICU). The most susceptible people are over 60 years old with comorbidities. The health systems organization may represent a transcendental role in survival. Objective: To analyze the correlation of sociodemographic factors, comorbidities and health system organization variables with survival in cases infected by SARS-CoV-2 during the first 7 months of the pandemic in Mexico. Methods: The cohort study was performed in a health system public basis from March 1st to September 30th, 2020. The included subjects were positive for the SARS-CoV-2 test, and the target variable was mortality in 60 days. The risk variables studied were: age, sex, geographic distribution, comorbidities, health system, hospitalization, and access to ICU. Bivariate statistics (X-2-test), calculation of fatality rates, survival analyses and adjustment of confusing variables with Cox proportional-hazards were performed. Results: A total of 753,090 subjects were analyzed, of which the 52% were men. There were 78,492 deaths (10.3% of general fatality and 43% inpatient). The variables associated with a higher risk of hospital mortality were age (from 60 years onwards), care in public sectors, geographic areas with higher numbers of infection and endotracheal intubation without management in the ICU. Conclusions: The variables associated with a lower survival in cases affected by SARS-CoV-2 were age, comorbidities, and respiratory insufficiency (with endotracheal intubation without care in the ICU). Additionally, an interaction was observed between the geographic location and health sector where they were treated.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Coronavirus Disease-2019 Survival in Mexico: A Cohort Study on the Interaction of the Associated Factors (vol 9, 660114, 2021)
    Marquez-Gonzalez, Horacio
    Mendez-Galvan, Jorge F.
    Reyes-Lopez, Alfonso
    Klunder-Klunder, Miguel
    Jimenez-Juarez, Rodolfo
    Garduno-Espinosa, Juan
    Solorzano-Santos, Fortino
    [J]. FRONTIERS IN PUBLIC HEALTH, 2021, 9
  • [2] A Study on Coronavirus Disease-2019 Stigma Associated with Coronavirus Disease-2019 Warriors and an Insight into Community Perception
    Gajula, Madhavi
    Madhukumar, Suwarna
    [J]. MEDENIYET MEDICAL JOURNAL, 2022, 37 (01): : 54 - 61
  • [3] Silent Hypoxia in Coronavirus disease-2019: Is it more dangerous? -A retrospective cohort study
    Sirohiya, Prashant
    Elavarasi, Arunmozhimaran
    Sagiraju, Hari Krishna Raju
    Baruah, Madhusmita
    Gupta, Nishkarsh
    Garg, Rohit Kumar
    Paul, Saurav Sekhar
    Ratre, Brajesh Kumar
    Singh, Ram
    Kumar, Balbir
    Vig, Saurabh
    Pandit, Anuja
    Kumar, Abhishek
    Garg, Rakesh
    Meena, Ved Prakash
    Mittal, Saurabh
    Pahuja, Saurabh
    Das, Nupur
    Dwivedi, Tanima
    Gupta, Ritu
    Kumar, Sunil
    Pandey, Manisha
    Mishra, Abhinav
    Matharoo, Karanvir Singh
    Mohan, Anant
    Guleria, Randeep
    Bhatnagar, Sushma
    [J]. LUNG INDIA, 2022, 39 (03) : 247 - 253
  • [4] Lymphocytes and Eosinophils Associated with the Coronavirus Disease-2019 Severity
    Kleebayoon, Amnuay
    Wiwanitkit, Viroj
    [J]. THORACIC RESEARCH AND PRACTICE, 2023, 24 (04) : 235 - +
  • [5] Coronavirus Disease-2019 in Pregnancy
    Rojas-Suarez, Jose
    Miranda, Jezid
    [J]. CLINICS IN CHEST MEDICINE, 2023, 44 (02) : 373 - 384
  • [6] Lung Transplantation for Coronavirus Disease-2019 Patients and Coronavirus Disease-2019 in Lung Transplant Recipients
    Avella, Diego
    Neumann, Henry
    Bharat, Ankit
    [J]. CLINICS IN CHEST MEDICINE, 2023, 44 (01) : 191 - 199
  • [7] Pneumomediastinum and pneumothorax in coronavirus disease-2019: Description of a case series and a matched cohort study
    Tekin, Aysun
    Devarajan, Anusha
    Sakata, Kenneth K.
    Qamar, Shahraz
    Sharma, Mayank
    Morales, Diana J. Valencia
    Malinchoc, Michael
    Talaei, Fahimeh
    Welle, Stephanie
    Taji, Jamil
    Khosa, Sandeep
    Sharma, Nikhil
    Brown, Meghan
    Lal, Amos
    Bansal, Vikas
    Khan, Syed Anjum
    Nou, Abigail T. La
    Sanghavi, Devang
    Cartin-Ceba, Rodrigo
    Kashyap, Rahul
    Gajici, Ognjen
    Domecq, Juan P.
    Azadeh, Natalya
    [J]. HELIYON, 2024, 10 (13)
  • [8] RE: Lymphocytes and Eosinophils Associated with the Coronavirus Disease-2019 Severity
    Duman, Dildar
    Karakurt, Zuhal
    Kocak, Nagihan Durmus
    Adiguzel, Nalan
    Yildiz, Tekin
    Gungor, Gokay
    Takir, Huriye Berk
    Tepetam, Fatma Merve
    Gunen, Hakan
    [J]. THORACIC RESEARCH AND PRACTICE, 2023, 24 (04)
  • [9] Coronavirus Disease-2019 Vaccine Hesitancy
    Hammershaimb, E. Adrianne
    Campbell, James D.
    O'Leay, Sean T.
    [J]. PEDIATRIC CLINICS OF NORTH AMERICA, 2023, 70 (02) : 243 - 257
  • [10] Coronavirus Disease-2019 in the Immunocompromised Host
    Bertini Jr, Christopher D.
    Khawaja, Fareed
    Sheshadri, Ajay
    [J]. CLINICS IN CHEST MEDICINE, 2023, 44 (02) : 395 - 406